MONROVIA, Calif., July 18, 2013 /PRNewswire/ -- STAAR Surgical
Company (NASDAQ: STAA) today announced that it will release its
financial results for the second quarter ended June 28, 2013 on Wednesday, July 31, 2013 after the market
close. The Company will host a conference call
and webcast on Wednesday, July 31,
2013 at 4:30 p.m. Eastern /
1:30 p.m.
Pacific to discuss the Company's second quarter
results and recent corporate developments. The dial-in number for
the conference call is 877-703-6105 for domestic participants and
857-244-7304 for international participants, both using the
passcode 23510067.
The Company will also be using slides to illustrate its second
quarter results and operational progress. The slides and live
webcast of the call can be accessed from the investor relations
section of the STAAR website at www.staar.com.
A taped replay of the conference call will also be available
beginning approximately one hour after the call's conclusion and
will be available for seven days. This replay can be accessed
by dialing 888-286-8010 for domestic callers and 617-801-6888 for
international callers, both using passcode 40120994 An
archived webcast will also be available at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 25 years, designs, develops, manufactures and markets
implantable lenses for the eye and delivery systems therefor. All
of these lenses are foldable, which permits the surgeon to insert
them through a small incision. STAAR's lens used in refractive
surgery as an alternative to LASIK is called an Implantable
Collamer® Lens or "ICL." A lens used to replace the natural lens
after cataract surgery is called an intraocular lens or "IOL." Over
350,000 Visian ICLs have been implanted to date; to learn more
about the ICL go to: www.visianinfo.com. STAAR has approximately
300 full time employees and markets lenses in over 60 countries.
Headquartered in Monrovia, CA, it
manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo,
CA; and Monrovia, CA. For
more information, please visit the Company's website at
www.staar.com.
Collamer® is the registered trademark for STAAR's proprietary
biocompatible collagen copolymer lens material.
CONTACT:
|
Investors
|
Media
|
|
EVC Group
|
EVC Group
|
|
Leigh
Salvo
|
Chris Gale
|
|
Doug Sherk
|
646-201-5431
|
|
415-568-9348
|
|
SOURCE STAAR Surgical Company